KLK3 and prostate cancer: The widespread use of prostate-specific antigen (PSA) in combination with other established risk factors to assist clinicians in the early detection of prostate cancer has fostered user-friendly online risk tools for assessing the chance of prostate cancer detection if a prostate biopsy were to be performed.